Your browser doesn't support javascript.
loading
A crosscut survey on reproductive health in Lithuanian childhood cancer survivors.
Stukaite-Ruibiene, Egle; Jurkonis, Mantas; Adomaitis, Robertas; Bumbuliene, Zana; Gudleviciene, Zivile; Verkauskas, Gilvydas; Zagminas, Kestutis; Vaiciuniene, Rasa; Rascon, Jelena.
Afiliação
  • Stukaite-Ruibiene E; Vilnius University, Faculty of Medicine, Lithuania.
  • Jurkonis M; Vilnius University, Faculty of Medicine, Lithuania.
  • Adomaitis R; Center for Pediatric Oncology and Hematology, Vilnius University, Lithuania.
  • Bumbuliene Z; Vilnius University, Faculty of Medicine, Lithuania.
  • Gudleviciene Z; Vilnius University, Faculty of Medicine, Lithuania.
  • Verkauskas G; Center of Obstetrics and Gynecology, Vilnius University, Lithuania.
  • Zagminas K; Center of Obstetrics and Gynecology, Vilnius University, Lithuania.
  • Vaiciuniene R; Vilnius University, Faculty of Medicine, Lithuania.
  • Rascon J; Center of Children's Surgery, Orthopedics and Traumatology, Vilnius University, Lithuania.
Ginekol Pol ; 92(4): 262-270, 2021.
Article em En | MEDLINE | ID: mdl-33757149
ABSTRACT

OBJECTIVES:

Sexual dysfunction was reported to compromise the quality of life in childhood cancer survivors. The aim of our study was to evaluate the reproductive health in long-term pediatric cancer survivors by conducting a crosscut survey. MATERIAL AND

METHODS:

Childhood cancer survivors over 18 years of age, who were in remission for more than 5 years, were invited to complete a gender-specific questionnaire surveying on their reproductive health. Demographic and treatment data were retrieved from their medical records. Treatment modalities were reviewed for its potential gonadotoxicity.

RESULTS:

34 (17 males and 17 females, respectively) from 346 addressed survivors (9.8%) completed the questionnaire. Median age and follow-up after diagnosis was 27 (18-35) and 14 (3-25) years, respectively. Some respondents reported sexual concerns 11.8% males experienced problems with penetration, two males (11.8%) who underwent semen analysis were found to be azoospermic. Similarly, 11.8% females reported delayed puberty, the average age of menarche was 14 (12-17) years, 29.4% females reported irregular menstrual cycles. Cyclophosphamide equivalent dose (CED) differed significantly between the patients treated for leukemia, lymphoma and solid tumors (3000 vs 4352 vs 6660 mg/m2, respectively, p = 0.014).

CONCLUSIONS:

Low prevalence of sexual dysfunction, fertility related disorders or delayed puberty in childhood cancer survivors was found. However, the results should be interpreted with caution taking into account a low response rate.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Ginekol Pol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Lituânia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Ginekol Pol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Lituânia